The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Related Posts
Trump and DOGE Propel V.A. Mental Health System Into Turmoil
A chaotic restructuring order threatens to degrade services for veterans of wars in Vietnam, Iraq and Afghanistan.
Malaria Is Surging in Ethiopia, Reversing a Decade of Progress Against the Disease
Climate change, civil conflict and growing resistance to insecticides and treatments are all contributing to an alarming spread of cases.
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have…